Ventures we've accelerated
Challenge
Implant-associated bacterial infections lack early, specific diagnostics and targeted treatment options, leading to delayed interventions, unnecessary revisions, and high healthcare costs.
Solution
Development of an antibody-guided theranostics platform enabling precise imaging and targeted therapy of bacterial infections, starting with Staphylococcus aureus.
Results
Defined the value proposition and clinical strategy. Secured funding for two clinical programs: Phase-0 imaging and a point-of-care synovial fluid diagnostic. Built branding, investor readiness, and strategic positioning. Established operational foundations and academic and clinical partnerships. Preparing the company for the next financing round to advance the broader pipeline.
Technology used
Antibody-based molecular imaging, photodynamic therapy, clinical diagnostics, translational clinical research.
Visit website
Challenge
Flow cytometry analysis is complex, labor-intensive, and highly dependent on expert interpretation, creating bottlenecks in clinical diagnostics.
Solution
A cloud-based AI decision-support platform that automates and standardizes flow cytometry analysis for clinical and research use.
Results
Developed the cloud-native software solution. Built the core team and operational structure. Implemented ISO 13485 quality management foundations. Achieved IVDR regulatory approval and established key partners.
Technology used
Artificial intelligence, cloud computing, medical software (SAAS), regulatory-grade data pipelines.
Visit website
Challenge
Clinical decision-making in knee arthroplasty lacks objective, data-driven diagnostics to optimize outcomes.
Solution
Positioning and development of a precision diagnostics approach to support better surgical and post-operative decisions.
Results
Defined market positioning and branding. Achieved operational readiness. Recruited and onboarded a dedicated CEO. Supported strategic direction and execution.
Technology used
Orthopaedic diagnostics, clinical data analysis, medical device innovation.
Visit website
Challenge
Esophageal cancer is often diagnosed late due to insufficient early-stage detection tools.
Solution
Advanced imaging technology aimed at early detection of esophageal cancer to improve patient outcomes.
Results
Supported founders in company formation and structuring. Assisted in securing early funding. Currently guiding investor readiness, branding, and strategic positioning for the next funding round.
Technology used
Advanced optical imaging, cancer diagnostics, translational research.
Challenge
Surgeons lack real-time visual guidance to accurately identify tumor tissue during procedures.
Solution
Development of fluorescence-guided solutions to improve precision in oncological surgery and interventions.
Results
Founded the company and built the initial team. Drove company development from early stage to exit. Successfully exited to Bracco.
Technology used
Fluorescence imaging, surgical guidance systems, interventional oncology technologies.
Visit website
Challenge
Complex minimally invasive procedures require higher precision and reproducibility than manual techniques allow.
Solution
Image-guided robotic systems enabling safer and more precise minimally invasive interventions.
Results
Defined company strategy and positioning. Built the team and branding. Prepared the company for investors and transactions. Supported the process through IP transfer to new investors.
Technology used
Medical robotics, image guidance, minimally invasive intervention technologies.
Visit website
Challenge
Existing imaging technologies are limited in sensitivity and multiplexing capabilities.
Solution
Development of next-generation quantum dot imaging platforms for advanced biomedical applications.
Results
Supported early company development. Assisted in securing the first funding rounds. Helped shape initial strategy and positioning.
Technology used
Quantum dots, advanced imaging, nanotechnology.
Visit website
Challenge
Delays in clinical decision-making negatively impact outcomes in time-critical conditions.
Solution
A multimodal AI agent platform that accelerates diagnosis and treatment workflows.
Results
Supported business development activities in Europe. Assisted with market entry and partner engagement.
Technology used
Artificial intelligence, multimodal data analysis, clinical workflow integration.
Visit website
Tell us about your venture
